Running away or righting the way: is psilocybin a viable psychiatric treatment?
[Due to the Controlled Substances Act of 1970] … absence of clinical evidence soon became a compounded issue. When there’s no research, attention tends to wane. Not only do clinical trials stop, but meta-analyses and trial reviews cease too. As a result, physician awareness and interest in exploring novel psychedelic therapies dwindles. “But when you…
Recent Comments